Regulation of lipid metabolism-related gene expression in whole blood cells of normo- and dyslipidemic men after fish oil supplementation

Lipids in Health and Disease

Volumn 11, Issue , 2012, Pages

  Schmidt, Simone ^a   Willers, Janina ^a   Stahl, Frank ^a   Mutz, Kai Oliver ^a   Scheper, Thomas ^a   Hahn, Andreas ^a   Schuchardt, Jan Philipp ^a  

^a LEIBNIZ UNIVERSITY HANNOVER   (Germany)

Author keywords

Dyslipidemia; HNF; Omega 3 fatty acids; PPAR ; RXR; TG lowering

Indexed keywords

2 ACYLGLYCEROL O ACYLTRANSFERASE 2; 2 ACYLGLYCEROL O ACYLTRANSFERASE 3; ABC TRANSPORTER G5; ACYLTRANSFERASE; APOLIPOPROTEIN C2; CHOLESTEROL ACYLTRANSFERASE; CHOLESTEROL ACYLTRANSFERASE 1; DIACYLGLYCEROL ACYLTRANSFERASE 1; DOCOSAHEXAENOIC ACID; FISH OIL; HEPATIC NUCLEAR FACTOR 1BETA; HEPATIC NUCLEAR FACTOR 6; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ICOSAPENTAENOIC ACID; LOW DENSITY LIPOPROTEIN RECEPTOR; MEMBRANE PROTEIN; NUCLEAR FACTOR; OMEGA 3 FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PHOSPHOLIPID TRANSFER PROTEIN; RETINOID X RECEPTOR ALPHA; RETINOID X RECEPTOR GAMMA; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ARTICLE; BLOOD CELL; BLOOD SAMPLING; CHOLESTEROL METABOLISM; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DYSLIPIDEMIA; GENE EXPRESSION; GENOME ANALYSIS; HUMAN; LIPID BLOOD LEVEL; LIPID METABOLISM; LIPOGENESIS; MALE; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PROTEIN BLOOD LEVEL; REAL TIME POLYMERASE CHAIN REACTION;

ADULT; CHOLESTEROL, HDL; DIETARY SUPPLEMENTS; DYSLIPIDEMIAS; FATTY ACIDS, OMEGA-3; FISH OILS; GENE EXPRESSION; GENOME, HUMAN; HUMANS; LIPID METABOLISM; LIPIDS; LIPOPROTEINS, LDL; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; PPAR ALPHA; TRIGLYCERIDES;

EID: 84870922416     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-11-172     Document Type: Article

References (79)

1. n-3 fatty acids and lipoproteins: comparison of results from human and animal studies. Harris WS, Lipids 1996 3 243 252 (Pubitemid 26094301)
2. n-3 fatty acids and serum lipoproteins: human studies. Harris WS, Am J Clin Nutr 1997 65 1645S 1654S 9129504 (Pubitemid 27187958)
3. Long-chain omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid dose-dependently reduce fasting serum triglycerides. Musa-Veloso K, Binns MA, Kocenas AC, Poon T, Elliot JA, Rice H, Oppedal-Olsen H, Lloyd H, Lemke S, Nutr Rev 2010 3 155 167
4. Omega-3 fatty acid concentrates in the treatment of moderate hypertriglyceridemia. Skulas-Ray AC, West SG, Davidson MH, Kris-Etherton PM, Expert Opin Pharmacother 2008 7 1237 1248 (Pubitemid 351721760)
5. Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review. Balk EM, Lichtenstein AH, Chung M, Kupelnick B, Chew P, Lau J, Atherosclerosis 2006 1 19 30 (Pubitemid 44468073)
6. n-3 fatty acid ethyl ester administration to healthy subjects and to hypertriglyceridemic patients reduces tissue factor activity in adherent monocytes. Tremoli E, Eligini S, Colli S, Maderna P, Risè P, Pazzucconi F, Marangoni F, Sirtori CR, Galli C, Arterioscler Thromb 1994 10 1600 1608
7. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Kris-Etherton PM, Harris WS, Appel LJ, Circulation 2002 21 2747 2757 (Pubitemid 35364932)
8. Omega-3 fatty acid supplementation accelerates chylomicron triglyceride clearance. Park Y, Harris WS, J Lipid Res 2003 3 455 463 (Pubitemid 37279692)
9. Moderate doses of EPA and DHA from re-esterified triacylglycerols but not from ethyl-esters lower fasting serum triacylglycerols in statin-treated dyslipidemic subjects: Results from a six month randomized controlled trial. Schuchardt JP, Neubronner J, Kressel G, Merkel M, von Schacky C C, Hahn A, Prostaglandins Leukot Essent Fatty Acids 2011 6 381 386
10. Fish oil-How does it reduce plasma triglycerides? Shearer GC, Savinova OV, Harris WS, Biochim Biophys Acta 2012 5 843 851
11. Dietary fish as a major component of a weight-loss diet: effect on serum lipids, glucose, and insulin metabolism in overweight hypertensive subjects. Mori TA, Bao DQ, Burke V, Puddey IB, Watts GF, Beilin LJ, Am J Clin Nutr 1999 5 817 825 (Pubitemid 29512906)
12. Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men. Mori TA, Burke V, Puddey IB, Watts GF, O'Neal DN, Best JD, Beilin LJ, Am J Clin Nutr 2000 5 1085 1094 (Pubitemid 30230554)
13. Omega-3 fatty acids alter lipoprotein subfraction distributions and the in vitro conversion of very low density lipoproteins to low density lipoproteins. Lu G, Windsor SL, Harris WS, J Nutr Biochem 1999 3 151 158 (Pubitemid 29101639)
14. Selective regulation of UGT1A1 and SREBP-1c mRNA expression by docosahexaenoic, eicosapentaenoic, and arachidonic acids. Caputo M, Zirpoli H, Torino G, Tecce MF, J Cell Physiol 2011 1 187 193
15. Suppression of VLDL secretion by cultured hepatocytes incubated with chylomicron remnants enriched in n-3 polyunsaturated fatty acids is regulated by hepatic nuclear factor-4alpha. López-Soldado I, Avella M, Botham KM, Biochim Biophys Acta 2009 12 1181 1189
16. N-3 polyunsaturated fatty acids suppress insulin-induced SREBP-1c transcription via reduced trans-activating capacity of LXRalpha. Howell G, Deng X, Yellaturu C, Park EA, Wilcox HG, Raghow R, Elam MB, Biochim Biophys Acta 2009 12 1190 1196
17. Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain. de Urquiza AM, Liu S, Sjöberg M, Zetterström RH, Griffiths W, Sjövall J, Perlmann T, Science 2000 5499 2140 2144 (Pubitemid 32001593)
18. Polyunsaturated fatty acids are FXR ligands and differentially regulate expression of FXR targets. Zhao A, Yu J, Lew J, Huang L, Wright SD, Cui J, DNA Cell Biol 2004 8 519 526 (Pubitemid 39050558)
19. PPARs and their effects on the cardiovascular system. Oyekan A, Clin Exp Hypertens 2011 5 287 293
20. Fatty acid regulation of gene expression: a genomic explanation for the benefits of the mediterranean diet. Clarke SD, Gasperikova D, Nelson C, Lapillonne A, Heird WC, Ann N Y Acad Sci 2002 967 283 298 12079856 (Pubitemid 34721914)
21. Mechanisms for the hypotriglyceridemic effect of marine omega-3 fatty acids. Davidson MH, Am J Cardiol 2006 4A 27i 33i
22. Dietary polyunsaturated fatty acids and hepatic gene expression. Jump DB, Thelen A, Mater M, Lipids 1999 34 209 S212 10.1007/BF02562292 10419152
23. Omega-3 polyunsaturated fatty acid regulation of gene expression. Price PT, Nelson CM, Clarke SD, Curr Opin Lipidol 2000 1 3 7 (Pubitemid 30148192)
24. Cardiovascular disease-related genes and regulation by diet. Vanden Heuvel JP, Curr Atheroscler Rep 2009 6 448 455
25. Different gene expression profiles in normo- and dyslipidemic men after fish oil supplementation: results from a randomized controlled trial. Schmidt S, Stahl F, Mutz K, Scheper T, Hahn A, Schuchardt JP, Lipids Health Dis 2012 1 105
26. Transcriptome-based identification of antioxidative gene expression after fish oil supplementation in normo- and dyslipidemic men. Schmidt S, Stahl F, Mutz K, Scheper T, Hahn A, Schuchardt JP, Nutri metabol 2012 1 45
27. Primer3 on the WWW for general users and for biologist programmers. Rozen S, Skaletsky H, Methods Mol Biol 2000 132 365 386 10547847
28. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Vandesompele J, de Preter K, Pattyn F, Poppe B, van Roy N, de Paepe A, Speleman F, Genome Biol 2002 3 RESEARCH0034 10.1186/gb-2002-3-7-research0034
29. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta. Forman BM, Chen J, Evans RM, Proc Natl Acad Sci USA 1997 9 4312 4317 (Pubitemid 27194238)
30. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. Kliewer SA, Sundseth SS, Jones SA, Brown PJ, Wisely GB, Koble CS, Devchand P, Wahli W, Willson TM, Lenhard JM, Lehmann JM, Proc Natl Acad Sci USA 1997 9 4318 4323 (Pubitemid 27194239)
31. Mechanism of action of fibrates on lipid and lipoprotein metabolism. Staels B, Dallongeville J, Auwerx J, Schoonjans K, Leitersdorf E, Fruchart JC, Circulation 1998 19 2088 2093 (Pubitemid 28512236)
32. Role of ApoCs in lipoprotein metabolism: functional differences between ApoC1, ApoC2, and ApoC3. Jong MC, Hofker MH, Havekes LM, Arterioscler Thromb Vasc Biol 1999 3 472 484 (Pubitemid 29135144)
33. Human apolipoprotein B: structure of carboxyl-terminal domains, sites of gene expression, and chromosomal localization. Knott TJ, Rall SC, Innerarity TL, Jacobson SF, Urdea MS, Levy-Wilson B, Powell LM, Pease RJ, Eddy R, Nakai H, Science 1985 4721 37 43 (Pubitemid 16221617)
34. Lipoprotein lipase: from gene to obesity. Wang H, Eckel RH, Am J Physiol Endocrinol Metab 2009 2 271 E288
35. Pathophysiologic role of hepatocyte nuclear factor 6. Wang K, Holterman A, Cell Signal 2012 1 9 16
36. Regulatory mechanisms controlling human hepatocyte nuclear factor 4alpha gene expression. Hatzis P, Talianidis I, Mol Cell Biol 2001 21 7320 7330 10.1128/MCB.21.21.7320-7330.2001 11585914 (Pubitemid 32953485)
37. Transcriptional regulation of human apolipoprotein genes ApoB, ApoCIII, and ApoAII by members of the steroid hormone receptor superfamily HNF-4, ARP-1, EAR-2, and EAR-3. Ladias JA, Hadzopoulou-Cladaras M, Kardassis D, Cardot P, Cheng J, Zannis V, Cladaras C, J Biol Chem 1992 22 15849 15860
38. Orphan receptor HNF-4 and liver-specific gene expression. Sladek FM, Receptor 1994 1 64
39. Fatty acyl-CoA thioesters are ligands of hepatic nuclear factor-4alpha. Hertz R, Magenheim J, Berman I, Bar-Tana J, Nature 1998 6675 512 516 (Pubitemid 28168984)
40. A review of the role of apolipoprotein C-II in lipoprotein metabolism and cardiovascular disease. Kei AA, Filippatos TD, Tsimihodimos V, Elisaf MS, Metab Clin Exp 2012 10.1016/j.metabol.2011.12.002
41. A good response to oil with medium- and long-chain fatty acids in body fat and blood lipid profiles of male hypertriglyceridemic subjects. Liu Y, Wang J, Zhang R, Zhang Y, Xu Q, Zhang J, Zhang Y, Zheng Z, Yu X, Jing H, Nosaka N, Kasai M, Aoyama T, Wu J, Xue C, Asia Pac J Clin Nutr 2009 3 351 358
42. Reference intervals for serum apolipoproteins A-I, A-II, B, C-II, C-III, and E in healthy Japanese determined with a commercial immunoturbidimetric assay and effects of sex, age, smoking, drinking, and Lp(a) level. Sakurabayashi I, Saito Y, Kita T, Matsuzawa Y, Goto Y, Clin Chim Acta 2001 1-2 87 95 23276522 (Pubitemid 32913584)
43. Dietary inclusion of salmon, herring and pompano as oily fish reduces CVD risk markers in dyslipidaemic middle-aged and elderly Chinese women. Zhang J, Wang C, Li L, Man Q, Meng L, Song P, Frøyland L, Du Z, Br J Nutr 2012 6 1 11
44. Evidence for regulated monoacylglycerol acyltransferase expression and activity in human liver. Hall AM, Kou K, Chen Z, Pietka TA, Kumar M, Korenblat KM, Lee K, Ahn K, Fabbrini E, Klein S, Goodwin B, Finck BN, J Lipid Res 2012 5 990 999
45. Identification of acyl coenzyme A:monoacylglycerol acyltransferase 3, an intestinal specific enzyme implicated in dietary fat absorption. Cheng D, Nelson TC, Chen J, Walker SG, Wardwell-Swanson J, Meegalla R, Taub R, Billheimer JT, Ramaker M, Feder JN, J Biol Chem 2003 16 13611 13614 (Pubitemid 36799893)
46. Characterization of acyl-coenzyme A:diacylglycerol acyltransferase (DGAT) enzyme of human small intestine. Hiramine Y, Tanabe T, J Physiol Biochem 2011 2 259 264
47. MGAT2, a monoacylglycerol acyltransferase expressed in the small intestine. Yen CE, Farese RV, J Biol Chem 2003 20 18532 18537
48. Identification of a gene encoding an acyl CoA:diacylglycerol acyltransferase, a key enzyme in triacylglycerol synthesis. Cases S, Smith SJ, Zheng YW, Myers HM, Lear SR, Sande E, Novak S, Collins C, Welch CB, Lusis AJ, Erickson SK, Farese RV, Proc Natl Acad Sci USA 1998 22 13018 13023 (Pubitemid 28509516)
49. Deficiency of the intestinal enzyme acyl CoA:monoacylglycerol acyltransferase-2 protects mice from metabolic disorders induced by high-fat feeding. Yen CE, Cheong M, Grueter C, Zhou P, Moriwaki J, Wong JS, Hubbard B, Marmor S, Farese RV, Nat Med 2009 4 442 446
50. Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking Dgat. Smith SJ, Cases S, Jensen DR, Chen HC, Sande E, Tow B, Sanan DA, Raber J, Eckel RH, Farese RV, Nat Genet 2000 1 87 90 (Pubitemid 30257043)
51. DGAT1 is not essential for intestinal triacylglycerol absorption or chylomicron synthesis. Buhman KK, Smith SJ, Stone SJ, Repa JJ, Wong JS, Knapp FF, Burri BJ, Hamilton RL, Abumrad NA, Farese RV, J Biol Chem 2002 28 25474 25479 (Pubitemid 34951861)
52. In contrast with docosahexaenoic acid, eicosapentaenoic acid and hypolipidaemic derivatives decrease hepatic synthesis and secretion of triacylglycerol by decreased diacylglycerol acyltransferase activity and stimulation of fatty acid oxidation. Berge RK, Madsen L, Vaagenes H, Tronstad KJ, Göttlicher M, Rustan AC, Biochem J 1999 343 Pt 1 191 197 10493929 (Pubitemid 29473895)
53. Chylomicron synthesis by intestinal cells in vitro and in vivo. van Greevenbroek MM, de Bruin TW, Atherosclerosis 1998 1 9 S16
54. Measurement of fasting serum apoB-48 levels in normolipidemic and hyperlipidemic subjects by ELISA. Sakai N, Uchida Y, Ohashi K, Hibuse T, Saika Y, Tomari Y, Kihara S, Hiraoka H, Nakamura T, Ito S, Yamashita S, Matsuzawa Y, J Lipid Res 2003 6 1256 1262 (Pubitemid 37279645)
55. Increased serum apolipoprotein B48 concentration in patients with metabolic syndrome. Kinoshita M, Ohnishi H, Maeda T, Yoshimura N, Takeoka Y, Yasuda D, Kusano J, Mashimo Y, Saito S, Shimamoto K, Teramoto T, J Atheroscler Thromb 2009 4 517 522
56. Induction of the phospholipid transfer protein gene accounts for the high density lipoprotein enlargement in mice treated with fenofibrate. Bouly M, Masson D, Gross B, Jiang XC, Fievet C, Castro G, Tall AR, Fruchart JC, Staels B, Lagrost L, Luc G, J Biol Chem 2001 28 25841 25847
57. Genome-wide identification of peroxisome proliferator response elements using integrated computational genomics. Lemay DG, Hwang DH, J Lipid Res 2006 7 1583 1587 (Pubitemid 44079913)
58. DNA sequences responsible for reduced promoter activity of human phospholipid transfer protein by fibrate. Tu AY, Albers JJ, Biochem Biophys Res Commun 1999 3 802 807
59. Human plasma phospholipid transfer protein causes high density lipoprotein conversion. Jauhiainen M, Metso J, Pahlman R, Blomqvist S, van Tol A, Ehnholm C, J Biol Chem 1993 6 4032 4036 (Pubitemid 23072937)
60. The mechanism of the remodeling of high density lipoproteins by phospholipid transfer protein. Settasatian N, Duong M, Curtiss LK, Ehnholm C, Jauhiainen M, Huuskonen J, Rye KA, J Biol Chem 2001 29 26898 26905
61. Plasma phospholipid transfer protein enhances transfer and exchange of phospholipids between very low density lipoproteins and high density lipoproteins during lipolysis. Tall AR, Krumholz S, Olivecrona T, Deckelbaum RJ, J Lipid Res 1985 7 842 851 (Pubitemid 15046448)
62. Regulation of the expression of key genes involved in HDL metabolism by unsaturated fatty acids. Kuang Y, Eric Paulson K, Lichtenstein AH, Lamon-Fava S, Br J Nutr 2012 6 1 9
63. Role of phospholipid transfer protein in high-density lipoprotein- mediated reverse cholesterol transport. Yazdanyar A, Yeang C, Jiang X, Curr Atheroscler Rep 2011 3 242 248
64. A receptor-mediated pathway for cholesterol homeostasis. Brown MS, Goldstein JL, Science 1986 4746 34 47 (Pubitemid 16037973)
65. Molecular medicine. The cholesterol quartet. Goldstein JL, Brown MS, Science 2001 5520 1310 1312
66. Modulation of blood cell gene expression by DHA supplementation in hypertriglyceridemic men. Dawson K, Zhao L, Adkins Y, Vemuri M, Rodriguez RL, Gregg JP, Kelley DS, Hwang DH, J Nutr Biochem 2011 6 616 621
67. Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion. Yu L, Hammer RE, Li-Hawkins J, von Bergmann K, Lutjohann D, Cohen JC, Hobbs HH, Proc Natl Acad Sci USA 2002 25 16237 16242 (Pubitemid 35462779)
68. Dietary fish oil regulates gene expression of cholesterol and bile acid transporters in mice. Kamisako T, Tanaka Y, Ikeda T, Yamamoto K, Ogawa H, Hepatol Res 2012 3 321 326
69. Fish oil promotes macrophage reverse cholesterol transport in mice. Nishimoto T, Pellizzon MA, Aihara M, Stylianou IM, Billheimer JT, Rothblat G, Rader DJ, Arterioscler Thromb Vasc Biol 2009 10 1502 1508
70. Fibrates modify the expression of key factors involved in bile-acid synthesis and biliary-lipid secretion in gallstone patients. Roglans N, Vázquez-Carrera M, Alegret M, Novell F, Zambón D, Ros E, Laguna JC, Sánchez RM, Eur J Clin Pharmacol 2004 12 855 861 (Pubitemid 38333675)
71. Acyl-coenzyme A:cholesterol acyltransferases. Chang T, Li B, Chang CCY, Urano Y, Am J Physiol Endocrinol Metab 2009 1 1 E9
72. Differential effects of omega-3 and omega-6 Fatty acids on gene expression in breast cancer cells. Hammamieh R, Chakraborty N, Miller S, Waddy E, Barmada M, Das R, Peel SA, Day AA, Jett M, Breast Cancer Res Treat 2007 1 7 16 (Pubitemid 47555330)
73. Fish-oil supplementation induces antiinflammatory gene expression profiles in human blood mononuclear cells. Bouwens M, van de Rest O, Dellschaft N, Bromhaar MG, de Groot LCPGM, Geleijnse JM, Müller M, Afman LA, Am J Clin Nutr 2009 2 415 424
74. Effect of docosahexaenoic acid-rich fish oil supplementation on human leukocyte function. Gorjão R, Verlengia R, de Lima TM, Soriano FG, Boaventura MFC, Kanunfre CC, Peres CM, Sampaio SC, Otton R, Folador A, Martins EF, Curi TCP, Portiolli EP, Newsholme P, Curi R, Clin Nutr 2006 6 923 938 (Pubitemid 44752719)
75. Gene expression profiling of whole blood: comparison of target preparation methods for accurate and reproducible microarray analysis. Vartanian K, Slottke R, Johnstone T, Casale A, Planck SR, Choi D, Smith JR, Rosenbaum JT, Harrington CA, BMC Genomics 2009 10 2 10.1186/1471-2164-10-2 19123946
76. Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages. Chinetti G, Griglio S, Antonucci M, Torra IP, Delerive P, Majd Z, Fruchart JC, Chapman J, Najib J, Staels B, J Biol Chem 1998 40 25573 25580 (Pubitemid 28475776)
77. Peroxisome proliferator-activated receptor alpha target genes. Mandard S, Müller M, Kersten S, Cell Mol Life Sci 2004 4 393 416 (Pubitemid 38316578)
78. A unique human blood-derived cell population displays high potential for producing insulin. Zhao Y, Huang Z, Lazzarini P, Wang Y, Di A, Chen M, Biochem Biophys Res Commun 2007 1 205 211 (Pubitemid 46990344)
79. On the utility of pooling biological samples in microarray experiments. Kendziorski C, Irizarry RA, Chen K, Haag JD, Gould MN, Proc Natl Acad Sci USA 2005 12 4252 4257 (Pubitemid 40397098)